Scaffold-Free Nerve Fibroblast Constructs for Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing nerve transections, such as autologous nerve grafting, face challenges including donor site morbidity, limited availability of nerve graft donors, and limitations in repairing larger nerve defects due to biocompatibility and immune rejection issues with existing scaffold-based nerve guidance channels.
Innovation Solution
Development of scaffold-free, three-dimensional nerve fibroblast constructs using adipose-derived stem cells, where nerve cells are grown on a confluent monolayer of fibroblasts that contract to form a self-organizing construct with a fibroblast sheath, eliminating the need for exogenous scaffolds and addressing biocompatibility concerns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous nerve grafting is used to repair nerve transections, then nerve regeneration can be achieved, but donor site morbidity and limited availability of nerve graft donors occur
Solution Approach 1:
The patent uses the patient's own adipose tissue to generate fibroblasts and nerve guidance channels, eliminating the need for a separate donor site. The adipose tissue is harvested from areas like the abdomen or thighs where it can be obtained with minimal morbidity, and the same tissue source provides both the structural framework and the cellular components needed for nerve regeneration.
Solution Approach 2:
Adipose tissue serves multiple functions in this invention: it provides the structural framework for the nerve guidance channel, serves as a source of fibroblasts that will populate the channel, and can be harvested from relatively non-critical areas. This multi-functionality from a single tissue source resolves the contradiction between achieving reliable nerve regeneration and avoiding donor site morbidity.
2Reliability
If scaffold-based nerve guidance channels are used to repair larger nerve defects, then nerve regeneration can be supported, but biocompatibility and immune rejection issues arise
Solution Approach 1:
The patent changes the fundamental parameter of scaffold composition from synthetic or allogeneic materials to autologous fibroblast-generated extracellular matrix. This parameter change transforms the material from being immunogenic to being biocompatible, as the patient's own cells create the structural framework that will not trigger immune rejection while still providing the necessary support for nerve regeneration.
Solution Approach 2:
Fibroblasts derived from patient-specific adipose tissue serve as intermediaries that translate the structural framework into a biocompatible nerve guidance channel. These fibroblasts populate the channel and generate extracellular matrix that is inherently biocompatible, mediating between the initial scaffold structure and the final nerve regeneration environment.
3Ease of manufacture
If synthetic materials are used for nerve guidance channels to allow property alteration, then porosity and mechanical strength can be controlled, but biocompatibility and cell adhesion are compromised
Solution Approach 1:
The patent creates a composite structure where synthetic or decellularized scaffold material provides the initial structural framework with controlled porosity and mechanical properties, while patient-specific fibroblasts populate this framework and generate biological extracellular matrix. This composite approach combines the manufacturing advantages of synthetic materials with the biocompatibility of living tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scaffold-free nerve fibroblast constructs promote nerve regeneration by providing a biocompatible, readily available conduit for repairing nerve transections and damaged nerve tissue, potentially overcoming the limitations of traditional grafting and scaffold-based technologies, including improved nerve conduction velocities and muscle mass maintenance.
Implementation Method 1
growing nerve cells on a static and confluent monolayer of fibroblasts without an exogenous scaffold and under conditions that induce the monolayer of fibroblasts to contract to generate a co-culture of fibroblast and nerve cells
Data Source
AI summary
The invention relates to scaffold-free three dimensional nerve fibroblast constructs and method of generating the nerve fibroblast constructs. The invention also relates to methods or repairing nerve transection and replacing damaged nerve tissue using the nerve fibroblast constructs of the invention.